Chennai records 21% YoY rise with sale of 6,951 residential units in H1 2022: Knight Frank India

Knight Frank India in its latest report, India Real Estate: H1 2022 (January – June 2022) cited that the Chennai residential market registered a 21% Year on Year (YoY)growth in sales in H1 2022.The city recorded sales of 6,951 housing units in H1 2022 compared to 5,751 housing units sold in H1 2021.The new home launches also increased by 40% YoY from 5,424 housing units in H1 2021 to 7,570 housing units in H1 2022. The weighted average price of residential properties in Chennai rose by an estimated 5% YoY to INR 4,242 per sq ft.

சென்னையை அடுத்த படப்பை பனப்பாக்கத்தில் ஹரிணி பில்டர்ஸ் நிறுவனத்தின் சார்பில் வீட்டுமனை பிரிவு விற்பனை துவக்கம்

ஹரிணி புரமோட்டர்ஸ் பிரைவேட் லிமிடெட் நிறுவனத்தின்75 வது திட்டமாக சென்னையை அடுத்த படப்பை - பனப்பாக்கத்தில் "ஸ்ரீ சாய் கார்டன்" DTCP - RERA அங்கீகாரம் பெற்றவீட்டுமனை பிரிவு மற்றும் தனி வீடுகள் குடியிருப்புகள்...

Home improvement top reason why Indians take instant personal loan, shows data from SimplyCash

Home improvement and medical emergencies are the top two reasons why majority of Indians, especially the millennials, opt for instant personal loan, shows analysis of data involving lakhs of users of SimplyCash, the instant loan app powered by the Hero Group.
In the last 12 months, 37% of all instant personal loans disbursed by the firm were taken for home improvement. This was followed by factors like medical emergencies (28%) and marriage and family functions (12%). About 5% of customers took a loan for education, be it for their child’s education or for upskilling their own skills. Other causes included business-related expenses (2%), holidays (2%) and paying off debt (2%).

Dr Agarwal’s Health Care raises over Rs 1,000 cr from TPG Growth, Temasek

Chennai-based Dr. Agarwal’s Health Care Ltd. (DAHCL) has closed a landmark fund raise of ₹1,050 crore from TPG Growth, the middle market and growth equity platform of alternative asset firm Texas Pacific Group which is one of the leading investment firms based out of the US, and from existing investor Temasek, a global investment company headquartered in Singapore. The investment round, which is India’s largest fund raise in the eyecare space, will also provide significant capital to fuel the company’s expansion plans and pave the way for an exit for existing investor, ADV Partners. The company also raised Rs. 270 crores investment from Temasek in 2019.